Reappraisal of cardiovascular risk factors in patients with chronic myeloproliferative neoplasms

Scientific paper - Original scientific paper

• Author: Ivan Krečak
• Author: Srdan Verstovsek
• Author: Marko Lucijanić
• Author's institution: University of Zagreb; School of Medicine
• Scientific / art field, discipline and subdiscipline: BIOMEDICINE AND HEALTHCARE; Clinical Medical Sciences; Internal Medicine

Abstract (english)

Cardiovascular (CV) risk factors are important contributors to thrombotic risk in the general population and in patients with chronic myeloproliferative neoplasms (MPNs). However, the role of CV risk factors is often masked by other disease features that have a strong prognostic impact regarding thrombotic risk in MPN patients. This review summarizes the contemporary knowledge and aspects that have not been addressed or lack consensus in the medical community. We propose multidisciplinary care for MPN patients with CV comorbidities and provide future directions that may be needed to appropriately manage CV risk factors in MPNs.

• Keywords (english): Cardiovascular Diseases / epidemiology; Cardiovascular Diseases / etiology; Heart Disease Risk Factors; Humans; Myeloproliferative Disorders / complications; Myeloproliferative Disorders / epidemiology; Myeloproliferative Disorders / therapy; Neoplasms; Risk Factors; Thrombosis
• Language: english
• Publication type: Scientific paper - Original scientific paper
• Publication status: Published
• Peer review: Peer review
• Publication version: Accepted version
• Journal title: Clinical advances in hematology & oncology
• Numbering: vol. 21, no. 10, pp. 541-548
• p-ISSN: 1543-0790
• URN:NBN: urn:nbn:hr:105:537991
• Publication: 2023-10
• Document URL: https://www.hematologyandoncology.net/archives/october-2023/reappraisal-of-cardiovascular-risk-factors-in-patients-with-chronic-myeloproliferative-neoplasms/
• Type of resource: Text
• Access conditions: Open access
• Created on: 2024-05-06 07:58:54